Edema News and Research

RSS
Edema means swelling caused by fluid in your body's tissues. It usually occurs in the feet, ankles and legs, but it can involve your entire body.
SAFLUTAN launched in United Kingdom and Spain

SAFLUTAN launched in United Kingdom and Spain

New Marketing Authorization Application for Rhucin submitted to the EMEA by Pharming

New Marketing Authorization Application for Rhucin submitted to the EMEA by Pharming

CORD I phase III clinical trial results of XIAFLEX published

CORD I phase III clinical trial results of XIAFLEX published

Millennium's sNDA to be reviewed by the FDA

Millennium's sNDA to be reviewed by the FDA

FDA: Randomized clinical trial necessary to better interpret Clolar’s efficacy and safety in adult AML

FDA: Randomized clinical trial necessary to better interpret Clolar’s efficacy and safety in adult AML

Genzyme’s supplemental NDA for treating adult AML with Clolar to be discussed by the FDA

Genzyme’s supplemental NDA for treating adult AML with Clolar to be discussed by the FDA

Thrombogenics issues business update and half year results

Thrombogenics issues business update and half year results

Medical journal article highlights the challenges faced by healthcare providers for treating patients with non-healing wounds

Medical journal article highlights the challenges faced by healthcare providers for treating patients with non-healing wounds

Alimera Sciences' $5 million extension of Series C financing closed

Alimera Sciences' $5 million extension of Series C financing closed

ETC contracts Histria International to install the first BARA-MED hyperbaric chamber in Romania

ETC contracts Histria International to install the first BARA-MED hyperbaric chamber in Romania

Cut back in research and development expenses helps to decrease losses in second quarter for Ico Therapeutics

Cut back in research and development expenses helps to decrease losses in second quarter for Ico Therapeutics

Lundbeck to launch Sabril in the US following FDA's NDA approval

Lundbeck to launch Sabril in the US following FDA's NDA approval

Aton Pharma markets preservative-free drugs for glaucoma

Aton Pharma markets preservative-free drugs for glaucoma

InterMune receives $20 million event payment from Roche for initiating the Phase 2b trial of RG7227/ ITMN-191

InterMune receives $20 million event payment from Roche for initiating the Phase 2b trial of RG7227/ ITMN-191

Genentech announces Phase III study results for Avastin (bevacizumab) in combination with chemo in HER2-negative breast cancer

Genentech announces Phase III study results for Avastin (bevacizumab) in combination with chemo in HER2-negative breast cancer

FDA approves Extavia for multiple sclerosis

FDA approves Extavia for multiple sclerosis

Snoring during pregnancy may mean greater risk for gestational diabetes

Snoring during pregnancy may mean greater risk for gestational diabetes

Factors linked to failure of corneal transplants

Factors linked to failure of corneal transplants

Algae may the key to SARS vaccine

Algae may the key to SARS vaccine

Columbia University licenses retinal imaging technology to PCAsso Diagnostics

Columbia University licenses retinal imaging technology to PCAsso Diagnostics